about
Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effectsAngiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat heartsEfferent pathways in sodium overload-induced renal vasodilation in ratsA1 noradrenergic neurons lesions reduce natriuresis and hypertensive responses to hypernatremia in rats.Blockade of Rostral Ventrolateral Medulla (RVLM) Bombesin Receptor Type 1 Decreases Blood Pressure and Sympathetic Activity in Anesthetized Spontaneously Hypertensive RatsPreventing tomorrow's sudden cardiac death in epilepsy today: what should physicians know about this?Furthering our understanding of SUDEP: the role of animal models.Mas receptor contributes to pregnancy-induced cardiac remodeling.Tachycardias and sudden unexpected death in epilepsy: a gold rush by an experimental route.Omega-3 fatty acid supplementation reduces resting heart rate of rats with epilepsy.Temporal lobe epilepsy and social behavior: an animal model for autism?Involvement of the median preoptic nucleus in blood pressure control.Repeated amygdala-kindled seizures induce ictal rebound tachycardia in rats.Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.Phenytoin is not involved with changes in heart rate of rats with epilepsyHibernating mammals in sudden cardiac death in epilepsy: what do they tell us?Cardiovascular protective effect of melatonin in sudden unexpected death in epilepsy: a hypothesisIs cold the new hot in sudden unexpected death in epilepsy? Effect of low temperature on heart rate of rats with epilepsyPremature ventricular complexes: How benign are they in epilepsy?Could the retrotrapezoid nucleus neurons tell us something about SUDEP?Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspringRole of dorsal raphe nucleus GHS-R1a receptors in the regulation of inhibitory avoidance and escape behaviors in ratsCoronary vasodilation impairment in pilocarpine model of epilepsy
P50
Q28390303-1CD69205-EDBD-4AA8-BB37-59B23852329CQ28580953-0A21E576-ED29-42CB-8992-22FB8FF5A28BQ34287557-93444C58-B09D-404E-8CB9-6A576C87FE58Q34988883-C08CE727-E378-496F-A241-740A08145C55Q36958919-0B407D63-32F7-46D3-BE1E-A03FE66C287AQ37147410-946C6328-B5AA-42F9-8629-FAFC29DB3AD5Q38794020-D2BAC37B-47A3-4532-8E2E-94CEC68CB81EQ39395081-8AC1071B-78B6-4D3D-A445-9C8395439CC3Q42876952-95FA90A0-789A-4BC6-A8EA-25664047F5ECQ45088025-86D1362F-6CAF-446F-BE3F-3BD8C8A37CD1Q46624322-EF15338F-552E-4883-A1A0-5707017B23A1Q46968090-C542CB6B-E8CC-4243-8581-2B31027842A1Q48899707-B839EECA-9077-42E3-B025-4F48C5411B5AQ53106519-B330BD35-4DF6-4186-BDA7-BA1494DE3C0DQ60977191-90A889C9-39B6-4854-9FC5-1766649CC8BAQ80136369-BFA142B2-4B9D-424D-A5B4-2D5257D173F5Q80760574-165B3BBF-F114-4FB3-A862-3D6E7CD27B34Q83043653-11FC8FB1-1D74-4445-8E40-52417D57F15DQ86274418-8DA5BCA5-2F71-4834-98F6-86496A0ACA51Q87737624-3374819C-B234-45F1-B315-90D1CFDEFE19Q90045899-748C247E-7A7A-455D-A9C0-28A77BCC6E4BQ92279612-5DF0839E-111F-4A5E-AD55-1C186D01CEF6Q93374466-7E72FACD-93C2-4D20-A6B4-B674CC5FD573
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Diego B. Colugnati
@ast
Diego B. Colugnati
@en
Diego B. Colugnati
@es
Diego B. Colugnati
@sl
type
label
Diego B. Colugnati
@ast
Diego B. Colugnati
@en
Diego B. Colugnati
@es
Diego B. Colugnati
@sl
prefLabel
Diego B. Colugnati
@ast
Diego B. Colugnati
@en
Diego B. Colugnati
@es
Diego B. Colugnati
@sl
P106
P1153
12240521300
P21
P31
P496
0000-0002-6565-0042